Prognostic significance of serum hepatocyte growth factor in clear cell renal cell carcinoma: Comparison with serum vascular endothelial growth factor

Journal of Medical Investigation

Volumn 55, Issue 1-2, 2008, Pages 106-111

  Tanimoto, Shuji ^a   Fukumori, Tomoharu ^b   El Moula, Gad ^b   Shiirevnyamba, Avirmed ^b   Kinouchi, Shinichiro ^b   Koizumi, Takahiro ^b   Nakanishi, Ryoichi ^b   Yamamoto, Yasuyo ^b   Taue, Ryuichi ^b   Yamaguchi, Kunihisa ^b   Nakatsuji, Hiroyoshi ^b   Kishimoto, Tomoteru ^b   Izaki, Hirofumi ^b   Oka, Natsuo ^b   Takahashi, Masayuki ^b   Kanayama, Hiro Omi ^b  

^a TAKAMATSU RED CROSS HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Diagnostic maker; Hepatocyte growth factor; Prognostic maker; Renal cell carcinoma; Vascular endothelial growth factor

Indexed keywords

SCATTER FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY CARCINOMA; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 43149083873     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.55.106     Document Type: Article

References (24)

1. Thompson IM, Peek M : Improvement in survival of patients with renal cell carcinoma - the role of the serendipitously detected tumor, J Urol 140 : 487-490, 1988
2. Thrasher JB, Paulson DF : Prognostic factors in renal cancer. Urol Clin North Am 20 : 247-262, 1993
3. Motzer RJ, Bander NH, Nanus DM : Renal-cell carcinoma. N Engl J Med 335 : 865-875, 1996
4. Strohmeyer T, Ackermann R : Classic and modern prognostic indicators in renal cell carcinoma. Review of the literature. Urol Int 47 : 203-212, 1991
5. Medeiros LJ, Gelb AB, Weiss LM : Renal cell carcinoma. Prognostic significance of morphologic parameters in 121 cases. Cancer 61 : 1639-1651, 1988
6. Fuhrman SA, Lasky LC, Limas C : Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 : 655-63, 1982
7. Folkman J : Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333 : 1757-1763, 1995
8. D'Amato RJ, Loughnan MS, Flynn E, Folkman J : Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91 : 4082-5, 1994
9. Denekamp J : Review article : angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol 66 : 181-196, 1993
10. Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F : Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Clin Cancer Res 3 : 2451-2458, 1997
11. Jacobsen J, Rasmuson T, Grankvist K, Ljungberg B : Vascular endothelial growth factor as prognostic factor in renal cell carcinoma. J Urol 163 : 343-347, 2000
12. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM : Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119 : 629-641, 1992
13. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM : Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90 : 1937-1941, 1993
14. Ho RT, Liew CT, Lai KN : The expression of hepatocyte growth factor (HGF) and interleukin 6 (IL-6) in damaged human liver and kidney tissues. Hepatogastroenterology 46 : 1904-1909, 1999
15. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T : Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 265 : F61-69, 1993
16. Cantley LG, Barros EJ, Gandhi M, Rauchman M, Nigam SK : Regulation of mitogenesis, motagenesis, and tubulogenesis by hepatocyte growth factor in renal collecting duct cell. Am J Physiol 267 : F271-280, 1994
17. Bellusci S, Moens G, Gaudino G, Comoglio P, Nakamura T, Thiery JP, Jouanneau J : Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9 : 1091-9, 1994
18. Pisters LL, el-Naggar AK, Luo W, Malpica A, Lin SH : C-met proto-oncogene expression in benign and malignant human renal tissues. J Urol 158 : 724-248, 1997
19. Wagatsuma S, Konno R, Sato S, Yajima A : Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 82 : 520-30, 1998
20. Horie S, Aruga S, Kawamata H, Okui N, Kakizoe T, Kitamura T : Biological role of HGF/MET pathway in renal cell carcinoma. J Urol 161 : 990-997, 1999
21. Natali PG, Prat M, Nicotra MR, Bigotti A, Olivero M, Comoglio PM, Di Renzo MF : Overexpression of the met/HGF receptor in renal cell carcinomas. Int J Cancer 69 : 212-217, 1996
22. Fleming ID : AJCC Cancer Staging Manual, 5th ed. Lippincott-Raven, Philadelphia, pp. 231-232, 1997
23. Lokich J : Spontaneous regression of metastatic renal cancer. Case report and literature review. Am J Clin Oncol 20 : 416-418, 1997
24. Newmark JR, Newmark GM, Epstein JI, Marshall FF : Solitary late recurrence of renal cell carcinoma. Urology 43 : 725-728, 1994